Skip to main content
. 2016 Dec 2;34(1):221–235. doi: 10.1007/s12325-016-0448-9

Fig. 2.

Fig. 2

24-h IOP control with BAK-preserved latanoprost (red), preservative-free tafluprost (green), and combined PF triple therapy (tafluprost and dorzolamide/timolol fixed combination) (yellow)